MEX:GEHC (USA)
Â
Common Stock
MXN
1,753.9
(0%)
Apr 1
Warning! GuruFocus detected
1 Severe warning sign
with GEHC.
Try a 7-Day Free Trial
to check it out.
What is a stock summary page? Click here for an overview.
Business Description
GE HealthCare Technologies Inc
NAICS : 923120
SIC : 7372
ISIN : US36266G1076
Share Class Description:
MEX:GEHC: Common StockCompare
Compare
Traded in other countries / regions
GEHC.USAGEHC34.BrazilL0T.GermanyGEHC.Mexico IPO Date
2023-01-05Description
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Financial Strength
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 0.31 | |||||
Equity-to-Asset | 0.26 | |||||
Debt-to-Equity | 1.11 | |||||
Debt-to-EBITDA | 2.55 | |||||
Interest Coverage | 5.15 | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | 1.95 | |||||
Beneish M-Score | -2.53 | |||||
WACC vs ROIC |
Growth Rank
3/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 3.5 | |||||
3-Year EBITDA Growth Rate | 0.9 | |||||
3-Year EPS without NRI Growth Rate | -4.6 | |||||
3-Year FCF Growth Rate | 4.2 | |||||
3-Year Book Growth Rate | -20.4 | |||||
Future 3-5Y EPS without NRI Growth Rate Estimate | 9.45 | |||||
Future 3-5Y Total Revenue Growth Rate Estimate | 3.83 |
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 9.45 | |||||
9-Day RSI | 24.24 | |||||
14-Day RSI | 36.57 | |||||
3-1 Month Momentum % | 13.19 | |||||
6-1 Month Momentum % | -2.17 | |||||
12-1 Month Momentum % | 22.67 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 1.04 | |||||
Quick Ratio | 0.83 | |||||
Cash Ratio | 0.3 | |||||
Days Inventory | 63.89 | |||||
Days Sales Outstanding | 60.52 | |||||
Days Payable | 93.18 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Dividend Yield % | 0.14 | |||||
Dividend Payout Ratio | 0.03 | |||||
Forward Dividend Yield % | 0.16 | |||||
5-Year Yield-on-Cost % | 0.14 | |||||
3-Year Average Share Buyback Ratio | -0.2 | |||||
Shareholder Yield % | 0.95 |
Profitability Rank
5/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 41.71 | |||||
Operating Margin % | 13.35 | |||||
Net Margin % | 10.14 | |||||
FCF Margin % | 8.24 | |||||
ROE % | 25.5 | |||||
ROA % | 6.1 | |||||
ROIC % | 7.35 | |||||
3-Year ROIIC % | -2.05 | |||||
ROC (Joel Greenblatt) % | 123.76 | |||||
ROCE % | 12.98 | |||||
Years of Profitability over Past 10-Year | 6 |
GF Value Rank
9/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PE Ratio | 18.38 | |||||
Forward PE Ratio | 18.36 | |||||
PE Ratio without NRI | 18 | |||||
PEG Ratio | 5.14 | |||||
PS Ratio | 1.86 | |||||
PB Ratio | 4.31 | |||||
Price-to-Free-Cash-Flow | 23.56 | |||||
Price-to-Operating-Cash-Flow | 18.72 | |||||
EV-to-EBIT | 13.99 | |||||
EV-to-Forward-EBIT | 13.05 | |||||
EV-to-EBITDA | 11.78 | |||||
EV-to-Forward-EBITDA | 11.2 | |||||
EV-to-Revenue | 2.2 | |||||
EV-to-Forward-Revenue | 2.1 | |||||
EV-to-FCF | 28.13 | |||||
Earnings Yield (Greenblatt) % | 7.14 | |||||
FCF Yield % | 4.3 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
GE HealthCare Technologies Inc Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil MXN) | 369,089.171 | ||
EPS (TTM) (MXN) | 82.303 | ||
Beta | - | ||
3-Year Sharpe Ratio | - | ||
3-Year Sortino Ratio | - | ||
Volatility % | 27.94 | ||
14-Day RSI | 36.57 | ||
14-Day ATR (MXN) | 3.494637 | ||
20-Day SMA (MXN) | 1753.9 | ||
12-1 Month Momentum % | 22.67 | ||
52-Week Range (MXN) | 1310 - 1912.5 | ||
Shares Outstanding (Mil) | 457.3 |
Piotroski F-Score Details
Year:
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
GE HealthCare Technologies Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
GE HealthCare Technologies Inc Stock Events
Event | Date | Price (MXN) | ||
---|---|---|---|---|
No Event Data |
GE HealthCare Technologies Inc Frequently Asked Questions
What is GE HealthCare Technologies Inc(MEX:GEHC)'s stock price today?
The current price of MEX:GEHC is MXN1753.90. The 52 week high of MEX:GEHC is MXN1912.50 and 52 week low is MXN1310.00.
When is next earnings date of GE HealthCare Technologies Inc(MEX:GEHC)?
The next earnings date of GE HealthCare Technologies Inc(MEX:GEHC) is 2025-04-30 Est..
Does GE HealthCare Technologies Inc(MEX:GEHC) pay dividends? If so, how much?
The Dividend Yield %  of GE HealthCare Technologies Inc(MEX:GEHC) is 0.14% (As of Today), Highest Dividend Payout Ratio of GE HealthCare Technologies Inc(MEX:GEHC) was 0.03. The lowest was 0.02. And the median was 0.03. The  Forward Dividend Yield % of GE HealthCare Technologies Inc(MEX:GEHC) is 0.16%. For more information regarding to dividend, please check our Dividend Page.
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |